{
    "root": "80d5d700-e711-462e-b291-3684a78d00b8",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Tradjenta",
    "value": "20250321",
    "ingredients": [
        {
            "name": "LINAGLIPTIN",
            "code": "3X29ZEJ4R2"
        }
    ],
    "indications": "tradjenta indicated adjunct diet exercise improve glycemic control adults type 2 diabetes mellitus .",
    "contraindications": "recommended tradjenta 5 mg orally daily ( 2.1 ) tradjenta taken without food ( 2.1 )",
    "warningsAndPrecautions": "tradjenta tablets available light red , round , biconvex , bevel-edged , film-coated tablets containing 5 mg linagliptin . tradjenta tablets debossed `` d5 `` one side boehringer ingelheim symbol side . supplied follows : bottles 30 ( ndc 0597-0140-30 ) bottles 90 ( ndc 0597-0140-90 ) cartons containing 10 blister cards 10 tablets ( 10 × 10 ) ( ndc 0597-0140-61 ) , institutional pack.if repackaging required , dispense tight container defined usp .",
    "adverseReactions": "tradjenta contraindicated patients hypersensitivity linagliptin excipients tradjenta , anaphylaxis , angioedema , exfoliative skin conditions , urticaria , bronchial hyperreactivity occurred [ ( 5.3 ) ( 6 ) ] .",
    "indications_original": "TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.",
    "contraindications_original": "The recommended dosage of TRADJENTA is 5 mg orally once daily ( 2.1 ) TRADJENTA can be taken with or without food ( 2.1 )",
    "warningsAndPrecautions_original": "TRADJENTA tablets are available as light red, round, biconvex, bevel-edged, film-coated tablets containing 5 mg of linagliptin. TRADJENTA tablets are debossed with \"D5\" on one side and the Boehringer Ingelheim symbol on the other side.\n                  They are supplied as follows:Bottles of 30 (NDC 0597-0140-30)Bottles of 90 (NDC 0597-0140-90)Cartons containing 10 blister cards of 10 tablets each (10 × 10) (NDC 0597-0140-61), institutional pack.If repackaging is required, dispense in a tight container as defined in USP.",
    "adverseReactions_original": "TRADJENTA is contraindicated in patients with hypersensitivity to linagliptin or any of the excipients in TRADJENTA, reactions such as anaphylaxis, angioedema, exfoliative skin conditions, urticaria, or bronchial hyperreactivity have occurred [see Warnings and Precautions (5.3) and Adverse Reactions (6)]."
}